SIPAI HEALTH (00314) repurchased 200,000 shares at a cost of approximately HKD 240,200 on June 10th.
Sino Biopharmaceutical Limited (00314) announced that on June 10, 2026, it repurchased 200,000 shares for approximately HK$240,200.
SIPAI HEALTH (00314) announced on June 10, 2026, that it will repurchase 200,000 shares at a cost of approximately HK$240,000.
Related Articles
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
HANXBIO-B (03378) spent 1.1521 million Hong Kong dollars to repurchase 43,800 shares on June 10th.
NUOBIKAN (02635): Cao Xiaoxue appointed as a member of the nomination committee.
WELLCELL H-NEW (02477) main shareholder, WELLCELL H-NEW Group, plans to sell a total of 576 million shares of the company.
RECOMMEND
